Scholarlink

<p>This article is coauthored by the parents of a young patient and the medical team who cared for her.Together, they recount their shared experience with tabelecleucel, a novel therapy for Epstein–Barr virus-associated post–transplant lymphoproliferative disease (EBV&#xa0;+&#xa0;PTLD). The patient’s parents offer a deeply personal perspective, reflecting on several years of struggle marked by unwavering hope and trust in the medical professionals who have supported their daughter throughout her journey. The pediatric hemato-oncologist who advocated for the use of tabelecleucel described the case as unique worldwide.Their joint testimony tells the remarkable story of how tabelecleucel, despite an initially unclear biological rationale, achieved a reversal of a severe case of EBV&#xa0;+&#xa0;PTLD that had progressed to a point considered beyond recovery and associated with a dire prognosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Tabelecleucel in Post-transplant Epstein–Barr Virus-Associated Lymphoproliferative Disease: Patient and Oncologist Perspectives

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月30日

查看全文
  • Antonio Perez-Martinez,
  • Anarbella Lastra Rodrigo,
  • Esther Ramos Boluda,
  • Berta Gonzalez Martinez,
  • Alida Alcolea Sánchez,
  • Francisco Hernandez Oliveros

摘要

This article is coauthored by the parents of a young patient and the medical team who cared for her.Together, they recount their shared experience with tabelecleucel, a novel therapy for Epstein–Barr virus-associated post–transplant lymphoproliferative disease (EBV + PTLD). The patient’s parents offer a deeply personal perspective, reflecting on several years of struggle marked by unwavering hope and trust in the medical professionals who have supported their daughter throughout her journey. The pediatric hemato-oncologist who advocated for the use of tabelecleucel described the case as unique worldwide.Their joint testimony tells the remarkable story of how tabelecleucel, despite an initially unclear biological rationale, achieved a reversal of a severe case of EBV + PTLD that had progressed to a point considered beyond recovery and associated with a dire prognosis.